| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Margot Thome | Q54567009 |
| P2093 | author name string | Margot Thome | |
| P2860 | cites work | c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB | Q22010238 |
| A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue | Q22010675 | ||
| BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma | Q24290366 | ||
| Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure | Q24290782 | ||
| CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B | Q24291024 | ||
| Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO | Q24303248 | ||
| CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation | Q24303589 | ||
| The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases | Q24532851 | ||
| CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. | Q24534877 | ||
| CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1 | Q24630605 | ||
| Structure of the SH3-guanylate kinase module from PSD-95 suggests a mechanism for regulated assembly of MAGUK scaffolding proteins | Q27637177 | ||
| T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response | Q73765165 | ||
| The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21 | Q73923494 | ||
| Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors | Q74137382 | ||
| Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines | Q74321402 | ||
| T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10 | Q74330395 | ||
| Mucosa-associated lymphoid tissue lymphoma | Q77376835 | ||
| c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function | Q77378951 | ||
| BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression | Q77601901 | ||
| T lymphocyte costimulation mediated by reorganization of membrane microdomains | Q77923394 | ||
| T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma | Q78447749 | ||
| Structural characterization of the intramolecular interaction between the SH3 and guanylate kinase domains of PSD-95 | Q27637181 | ||
| Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase | Q28116219 | ||
| The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling | Q28139111 | ||
| CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10 | Q28140452 | ||
| mE10, a novel caspase recruitment domain-containing proapoptotic molecule | Q28140500 | ||
| Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32) | Q28143651 | ||
| Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation | Q28189327 | ||
| Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction | Q28198772 | ||
| CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis | Q28199393 | ||
| Marginal-zone B cells | Q28201000 | ||
| NF-kappaB regulation in the immune system | Q28205043 | ||
| Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway | Q28206030 | ||
| Themes and variations on ubiquitylation | Q28206411 | ||
| Autoreactivity by design: innate B and T lymphocytes | Q28208367 | ||
| A requirement for CARMA1 in TCR-induced NF-kappa B activation | Q28216751 | ||
| The CARD domain: a new apoptotic signalling motif | Q28239887 | ||
| PDZ domains: targeting signalling molecules to sub-membranous sites | Q28242408 | ||
| Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types | Q28297278 | ||
| Differential Requirement for Malt1 in T and B Cell Antigen Receptor Signaling | Q28505229 | ||
| PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling | Q28509628 | ||
| The MAGUK family protein CARD11 is essential for lymphocyte activation | Q28511124 | ||
| Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation | Q28586423 | ||
| Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells | Q28590075 | ||
| Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase | Q28591729 | ||
| Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha | Q28613845 | ||
| Immunodeficiency in protein kinase cbeta-deficient mice | Q28616043 | ||
| Signal transduction by lymphocyte antigen receptors | Q29619894 | ||
| MAGUK SH3 domains--swapped and stranded by their kinases? | Q30167602 | ||
| Regulation of naive T cell differentiation by varying the potency of TCR signal transduction | Q33707523 | ||
| Protein modules as organizers of membrane structure | Q33712466 | ||
| Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family | Q33750222 | ||
| Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway | Q33888844 | ||
| Conference highlight: do T cells care about the mitogen-activated protein kinase signalling pathways? | Q33890366 | ||
| Genetic abnormalities in marginal zone B-cell lymphoma | Q33910617 | ||
| The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells | Q34048761 | ||
| The death domain superfamily: a tale of two interfaces? | Q34086769 | ||
| Th1 and Th2 cells | Q34118616 | ||
| Membrane lipid microdomains and the role of PKCtheta in T cell activation | Q34222554 | ||
| IL-4 signaling, gene transcription regulation, and the control of effector T cells | Q34303143 | ||
| CD28-mediated co-stimulation: a quantitative support for TCR signalling | Q34543577 | ||
| Antigen-dependent B-cell development | Q34547252 | ||
| Regulation of B cell fates by BCR signaling components | Q34612524 | ||
| B cell antigen receptor signaling: roles in cell development and disease. | Q34662623 | ||
| Regulation of thymocyte differentiation: pre-TCR signals and beta-selection | Q34831686 | ||
| Transducing signals from antigen receptors to nuclear factor kappaB. | Q35129723 | ||
| TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1. | Q35196408 | ||
| Update: gastric MALT lymphoma | Q35213909 | ||
| Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. | Q35571851 | ||
| An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis | Q35834615 | ||
| Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function | Q36370717 | ||
| Nuclear factor kappa B is required for the development of marginal zone B lymphocytes | Q36376076 | ||
| Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling | Q40739732 | ||
| Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. | Q40870297 | ||
| Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology | Q41039639 | ||
| Defective B cell development and function in Btk-deficient mice | Q41306033 | ||
| NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death | Q42830133 | ||
| Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. | Q44485224 | ||
| Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes | Q44515868 | ||
| The physical association of protein kinase C theta with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28. | Q46106754 | ||
| Two pathways to NF-kappaB. | Q46113107 | ||
| Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. | Q48009840 | ||
| Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development | Q49240035 | ||
| Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides | Q50118523 | ||
| c-Rel is essential for B lymphocyte survival and cell cycle progression. | Q52036149 | ||
| Immature thymocytes that fail to express TCRbeta and/or TCRgamma delta proteins die by apoptotic cell death in the CD44(-)CD25(-) (DN4) subset. | Q52126537 | ||
| Impaired expansion of mouse B cell progenitors lacking Btk. | Q52507966 | ||
| Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. | Q52533403 | ||
| Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. | Q52533405 | ||
| Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas | Q57636706 | ||
| PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes | Q58617364 | ||
| Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells | Q59647697 | ||
| Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression | Q62817899 | ||
| Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization | Q71028547 | ||
| NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development | Q73291757 | ||
| Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma | Q73756605 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 348-359 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Nature Reviews Immunology | Q43355 |
| P1476 | title | CARMA1, BCL-10 and MALT1 in lymphocyte development and activation | |
| P478 | volume | 4 |
| Q37187515 | A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation |
| Q36979888 | A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency |
| Q33237976 | A loss-of-function RNA interference screen for molecular targets in cancer |
| Q61905387 | A pair of 9s: it's in the CARDs |
| Q36089051 | A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways |
| Q37038505 | A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma |
| Q36596980 | A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation |
| Q35943981 | ADAP regulates cell cycle progression of T cells via control of cyclin E and Cdk2 expression through two distinct CARMA1-dependent signaling pathways |
| Q26765188 | API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis |
| Q24322497 | Adaptors discriminate mast-cell cytokine production from eicosanoid production and degranulation |
| Q40484483 | Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors |
| Q33716323 | Alterations of tumor-related genes do not exactly match the histopathological grade in gastric adenocarcinomas |
| Q33653469 | Altered thymic selection by overexpressing cellular FLICE inhibitory protein in T cells causes lupus-like syndrome in a BALB/c but not C57BL/6 strain |
| Q24339441 | Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stress-induced cell death |
| Q34833062 | An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins |
| Q34080225 | Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. |
| Q34598995 | Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K. |
| Q49571552 | Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome. |
| Q37979413 | B-1 B cell development in the fetus and adult |
| Q34314392 | B-1a transitional cells are phenotypically distinct and are lacking in mice deficient in IκBNS. |
| Q35895262 | BCL10 is recruited to sites of DNA damage to facilitate DNA double-strand break repair |
| Q33952979 | BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response |
| Q33298653 | BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells |
| Q35575886 | Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production |
| Q24301605 | Bcl10 can promote survival of antigen-stimulated B lymphocytes |
| Q37418406 | Biochemical signaling pathways for memory T cell recall |
| Q37728922 | C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses |
| Q52308826 | CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation. |
| Q35613421 | CARMA1 is necessary for optimal T cell responses in a murine model of allergic asthma |
| Q24548028 | CARMA1 is required for Akt-mediated NF-kappaB activation in T cells |
| Q33855051 | CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling |
| Q35809995 | CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation. |
| Q28295777 | CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis |
| Q24295025 | Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation |
| Q34470356 | Calcium-activated pathways and oxidative burst mediate zymosan-induced signaling and IL-10 production in human macrophages |
| Q28504584 | Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity |
| Q61796300 | Caspase recruitment domains for protein interactions in cellular signaling (Review) |
| Q35906438 | Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. |
| Q36430147 | Caspases at the crossroads of immune-cell life and death |
| Q24296240 | Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1 |
| Q37748608 | Cbl-b in T-cell activation |
| Q84906148 | Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3 |
| Q33530203 | Chemical biology strategy reveals pathway-selective inhibitor of NF-kappaB activation induced by protein kinase C |
| Q35968270 | Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution. |
| Q24613755 | Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma |
| Q35155236 | Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation |
| Q58063928 | Comparative expressed sequence hybridization studies of t(11;18)(q21;q21)-positive and -negative gastric MALT lymphomas reveal both unique and overlapping gene programs |
| Q34983966 | Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL). |
| Q36133144 | Control of lymphocyte development by nuclear factor-kappaB. |
| Q37207024 | Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells |
| Q27660497 | Crystal Structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 Complexes: Affinity, Specificity, and Regulation |
| Q34027879 | DNA methylation modifications associated with chronic fatigue syndrome |
| Q35298358 | Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3-positive regulatory versus T(H)2 effector cells to cause allergy |
| Q41791606 | Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells. |
| Q43198922 | Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells |
| Q40899317 | Delving deeper into MALT lymphoma biology |
| Q52894682 | Dephosphorylation of Bcl-10 by calcineurin is essential for canonical NF-κB activation in Th cells. |
| Q34637731 | Design, Assessment, and in vivo Evaluation of a Computational Model Illustrating the Role of CAV1 in CD4(+) T-lymphocytes. |
| Q37353796 | Differential requirement for CARMA1 in agonist-selected T-cell development |
| Q33622342 | Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer? |
| Q24299762 | Discs large (Dlg1) complexes in lymphocyte activation |
| Q49911437 | Dynamic Cycling of t-SNARE Acylation Regulates Platelet Exocytosis |
| Q37414718 | Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma |
| Q50335551 | Essential function for the kinase TAK1 in innate and adaptive immune responses |
| Q37446487 | Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. |
| Q28649793 | Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma |
| Q24304887 | FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells |
| Q81828132 | FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations |
| Q36654209 | Fcepsilon- and Fcgamma-receptor signaling in diseases |
| Q36990608 | From T-cell activation signals to signaling control of anti-cancer immunity |
| Q37741791 | Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development |
| Q36973638 | Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity |
| Q38739035 | Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations. |
| Q52582248 | Genetics of diffuse large B cell lymphoma. |
| Q30832554 | Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways |
| Q38100784 | Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphoma |
| Q89485962 | Human BCL10 Deficiency due to Homozygosity for a Rare Allele |
| Q36340857 | Human lymphoma mutations reveal CARD11 as the switch between self-antigen-induced B cell death or proliferation and autoantibody production. |
| Q34630390 | IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function |
| Q35848596 | IKK biology |
| Q36294357 | IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells. |
| Q36637874 | IkappaB kinase complexes: gateways to NF-kappaB activation and transcription |
| Q64946812 | Immune cell subset differentiation and tissue inflammation. |
| Q37534555 | Immune-Related Gene Expression Patterns in GPV- or H9N2-Infected Goose Spleens |
| Q64093101 | Impaired CpG Demethylation in Common Variable Immunodeficiency Associates With B Cell Phenotype and Proliferation Rate |
| Q24306407 | Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity |
| Q34683996 | Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase |
| Q39785748 | Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells |
| Q33580752 | Inhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules |
| Q50291411 | Interaction of Bcl10 to CARMA1 |
| Q39726720 | Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells |
| Q38647675 | In vitro reconstitution of interactions in the CARD9 signalosome |
| Q36608215 | Itch-/- alphabeta and gammadelta T cells independently contribute to autoimmunity in Itchy mice |
| Q39214586 | Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation |
| Q37979179 | L-CBM signaling in lymphocyte development and function |
| Q41343171 | LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation. |
| Q36858872 | Life and death in peripheral T cells |
| Q30157021 | MAGUK-controlled ubiquitination of CARMA1 modulates lymphocyte NF-kappaB activity |
| Q41625334 | MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage |
| Q34474895 | MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells |
| Q63409870 | MALT1 directs B cell receptor–induced canonical nuclear factor-κB signaling selectively to the c-Rel subunit |
| Q37936211 | Malignant pirates of the immune system |
| Q58693356 | Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice |
| Q34211312 | Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. |
| Q34126537 | Molecular basis of lysophosphatidic acid-induced NF-κB activation |
| Q37944372 | Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type |
| Q36435203 | Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein |
| Q36477917 | Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management |
| Q36584820 | Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists. |
| Q36870112 | Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance |
| Q37198925 | Multifunctional roles for MALT1 in T-cell activation. |
| Q42433984 | Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production. |
| Q87023196 | N-Ethyl-N-nitrosourea mutagenesis in the mouse provides strong genetic and in vivo evidence for the role of the Caspase Recruitment Domain (CARD) of CARD-MAGUK1 in T regulatory cell development |
| Q33799578 | NF-kappaB activation in T cells requires discrete control of IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation and IKKgamma ubiquitination by the ADAP adapter protein |
| Q28271031 | NF-kappaB and the immune response |
| Q36417751 | NF-kappaB guides the survival and differentiation of developing lymphocytes |
| Q54247368 | NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy. |
| Q38172394 | NF-κB control of T cell development |
| Q35348282 | NF-κB in immunobiology. |
| Q47846592 | NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome |
| Q41522612 | Negative role of TAK1 in marginal zone B-cell development incidental to NF-κB noncanonical pathway activation |
| Q24633118 | Nore1B regulates TCR signaling via Ras and Carma1 |
| Q26752380 | Notch Signaling in Neuroendocrine Tumors |
| Q27680595 | Novel Disulfide Bond-Mediated Dimerization of the CARD Domain Was Revealed by the Crystal Structure of CARMA1 CARD |
| Q83197527 | Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation |
| Q35947243 | Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma |
| Q29547879 | Nuclear factor-kappaB in cancer development and progression |
| Q50291413 | Oligomerization of Bcl10 |
| Q33849388 | Oncogenic activation of NF-kappaB. |
| Q46715689 | Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma |
| Q35843746 | PI3Ks in lymphocyte signaling and development |
| Q24646391 | PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1 |
| Q26777188 | PKC-Theta in Regulatory and Effector T-cell Functions |
| Q57961999 | PKC-θ: hitting the bull's eye |
| Q36328818 | PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways |
| Q47140457 | PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development. |
| Q34245261 | Pathogenesis of human B cell lymphomas |
| Q33889168 | Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies |
| Q89138330 | Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression |
| Q36944827 | Phospholipase Cgamma2 mediates RANKL-stimulated lymph node organogenesis and osteoclastogenesis |
| Q42412360 | Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation |
| Q37321154 | Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells |
| Q28116780 | Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation |
| Q82680896 | Proliferating γδ T cells manifest high and spatially confined caspase-3 activity |
| Q24337298 | Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL |
| Q28115184 | Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome |
| Q55106506 | Recent advances in understanding the biology of marginal zone lymphoma. |
| Q95323063 | Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development |
| Q35920998 | Regulation of NF-κB by the CARD proteins |
| Q37814066 | Regulation of NF-κB signaling by caspases and MALT1 paracaspase |
| Q36287472 | Regulation of phospholipase C-gamma2 networks in B lymphocytes |
| Q35990308 | Regulation of the PKCθ-NF-κB Axis in T Lymphocytes by the Tumor Necrosis Factor Receptor Family Member OX40 |
| Q36092258 | Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma |
| Q38831146 | Rewired NFκB signaling as a potentially actionable feature of activated B-cell-like diffuse large B-cell lymphoma. |
| Q33800318 | Roles of the NF-kappaB pathway in lymphocyte development and function |
| Q33497042 | STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells |
| Q39209790 | STUB1 is essential for T-cell activation by ubiquitinating CARMA1. |
| Q28509606 | Scaffold protein Dlgh1 coordinates alternative p38 kinase activation, directing T cell receptor signals toward NFAT but not NF-kappaB transcription factors |
| Q39773860 | Serine 649 phosphorylation within the protein kinase C-regulated domain down-regulates CARMA1 activity in lymphocytes |
| Q35216729 | Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan |
| Q27671461 | Structural Insights into the Assembly of CARMA1 and BCL10 |
| Q91809396 | Structures of autoinhibited and polymerized forms of CARD9 reveal mechanisms of CARD9 and CARD11 activation |
| Q36843595 | Supramolecular organizing centers (SMOCs) as signaling machines in innate immune activation |
| Q48136905 | Synergistic cooperation and crosstalk between MYD88L265P and mutations that dysregulate CD79B and surface IgM. |
| Q34772947 | Synthesis and physicochemical characterization of novel phenotypic probes targeting the nuclear factor-kappa B signaling pathway |
| Q35510049 | T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10. |
| Q34174201 | T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. |
| Q36498083 | T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b |
| Q39880938 | TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB. |
| Q99594459 | Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study |
| Q38085501 | Targeting pathological B cell receptor signalling in lymphoid malignancies |
| Q28587567 | The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation |
| Q36634002 | The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes |
| Q34074217 | The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis |
| Q33840233 | The CBM signalosome: potential therapeutic target for aggressive lymphoma? |
| Q24296770 | The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4 |
| Q36268334 | The NF-kappaB signalling pathway: a therapeutic target in lymphoid malignancies? |
| Q49852317 | The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition. |
| Q99241373 | The adaptor protein CARD9, from fungal immunity to tumorigenesis |
| Q43205690 | The biology and biochemistry of inflammatory signalosomes. Meeting on signaling networks in immunity and inflammation |
| Q33996534 | The death domain superfamily in intracellular signaling of apoptosis and inflammation |
| Q26866537 | The genetic landscape of diffuse large B-cell lymphoma |
| Q54595193 | The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. |
| Q43119003 | The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation |
| Q36710770 | The pathogenesis of MALT lymphomas: where do we stand? |
| Q35025935 | The pleckstrin homology domain in the SKAP55 adapter protein defines the ability of the adapter protein ADAP to regulate integrin function and NF-kappaB activation |
| Q34748769 | The proteolytic activity of the paracaspase MALT1 is key in T cell activation |
| Q38113623 | The role of CARMA1 in T cells. |
| Q36221500 | The transcriptome of the fetal inflammatory response syndrome |
| Q34438768 | Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome |
| Q36453359 | Transcriptional basis of lymphocyte tolerance. |
| Q50291408 | Translocation of CARMA1 to Plasma membrane |
| Q36239551 | Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation |
| Q38789324 | Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCβ Kinase Activity |
| Q37374154 | c-FLIP(S) reduces activation of caspase and NF-kappaB pathways and decreases T cell survival |
| Q61628000 | c-Rel but not NF-κB1 is important for T regulatory cell development |
| Q54706737 | c-Rel phenocopies PKCtheta but not Bcl-10 in regulating CD8+ T-cell activation versus tolerance. |
| Q36405075 | cFLIP regulation of lymphocyte activation and development |
Search more.